CM
Caption Management Portfolio holdings
AUM
$1.09B
1-Year Return
4.13%
This Quarter Return
+1.45%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$908M
AUM Growth
-$11.7M
(-1.3%)
Cap. Flow
-$36.2M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
45.15%
Holding
1,012
New
186
Increased
87
Reduced
75
Closed
257
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$19.4M |
| 2 |
Meta Platforms (Facebook)
META
|
$16.3M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$15.7M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$13.8M |
| 5 |
Pilgrim's Pride
PPC
|
$12.6M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$21.3M |
| 2 |
Palo Alto Networks
PANW
|
$19.6M |
| 3 |
Cigna
CI
|
$16.5M |
| 4 |
Charter Communications
CHTR
|
$14.3M |
| 5 |
NextEra Energy, Inc.
NEE
|
$11.4M |
Sector Composition
| 1 | Healthcare | 19.84% |
| 2 | Communication Services | 18.73% |
| 3 | Financials | 15.67% |
| 4 | Technology | 11.62% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
REX American Resources
REX
$1.02B
| $557K | 0.01% |
9,493
-12,365
| -57% | -$726K |
|
202
Evolv Technologies
EVLV
$1.39B
| $550K | 0.01% |
123,500
+19,561
| +19% | +$87K |
|
203
Warner Bros
WBD
$30B
| $546K | 0.01% |
62,500
+48,400
| +343% | +$423K |
|
204
Box
BOX
$4.75B
| $538K | 0.01% |
19,000
+6,000
| +46% | +$170K |
|
205
Fortrea Holdings
FTRE
$1.06B
| $530K | 0.01% |
+13,200
| New | +$530K |
|
206
Madison Square Garden
MSGS
$4.71B
| $529K | 0.01% |
2,868
-18,036
| -86% | -$3.33M |
|
207
Macy's
M
$4.64B
| $522K | 0.01% |
26,100
-39,600
| -60% | -$792K |
|
208
EchoStar
SATS
$19.3B
| $520K | 0.01% |
+36,500
| New | +$520K |
|
209
Melco Resorts & Entertainment
MLCO
$3.8B
| $519K | 0.01% |
72,000
-57,211
| -44% | -$412K |
|
210
Leggett & Platt
LEG
$1.35B
| $494K | 0.01% |
25,778
-14,222
| -36% | -$272K |
|
|
HCP
211
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $488K | 0.01% |
+18,100
| New | +$488K |
|
212
Inogen
INGN
$219M
| $484K | 0.01% |
+60,000
| New | +$484K |
|
213
Future Fuel
FF
$173M
| $483K | 0.01% |
+60,000
| New | +$483K |
|
214
Guess, Inc.
GES
$878M
| $476K | 0.01% |
+15,121
| New | +$476K |
|
|
PTVE
215
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $465K | 0.01% |
+32,500
| New | +$465K |
|
|
ALTM
216
DELISTED
Arcadium Lithium plc
ALTM
| $455K | 0.01% |
+105,647
| New | +$455K |
|
217
Revolution Medicines
RVMD
$7.57B
| $451K | 0.01% |
+14,000
| New | +$451K |
|
|
TRTX
218
TPG RE Finance Trust
TRTX
$761M
| $450K | 0.01% |
+58,296
| New | +$450K |
|
219
Anywhere Real Estate
HOUS
$724M
| $446K | 0.01% |
+72,193
| New | +$446K |
|
220
Braze
BRZE
$3.5B
| $443K | 0.01% |
+10,000
| New | +$443K |
|
221
Equinox Gold
EQX
$7.65B
| $442K | 0.01% |
+73,500
| New | +$442K |
|
222
Oric Pharmaceuticals
ORIC
$1.06B
| $439K | 0.01% |
31,900
-63,360
| -67% | -$871K |
|
223
Viridian Therapeutics
VRDN
$1.53B
| $438K | 0.01% |
+25,000
| New | +$438K |
|
224
Insulet
PODD
$24.5B
| $438K | 0.01% |
2,553
-47
| -2% | -$8.06K |
|
225
Intellia Therapeutics
NTLA
$1.29B
| $430K | 0.01% |
+15,616
| New | +$430K |
|